Amgen Inc.
Michael V Drake (Director) reports AMGN insider transactions
AI-generated summary
Director Michael V Drake received 114.0263 shares as a grant of Common Stock on November 6, 2026. Following this transaction, Michael V Drake directly held 6,030.1896 shares of Common Stock.
Key facts
- Insider
- Michael V Drake · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | A · grantFootnotes F1, F2 | +114.0263 | $0.00 | $0.00 | 6,030.1896 | Direct |
Footnotes
- F1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.
- F2 These shares include 417 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
More AMGN filings
- 4
Filed Nov 9, 2026
- 4
Filed Nov 9, 2026
- 4
Filed Nov 9, 2026
- 8-K
Filed Nov 3, 2026
- 10-Q
Filed Nov 3, 2026
- 3
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.